Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5230_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
15.09.2026
Размер:
17 Мб
Скачать
☆
Melanocytic naevi (moles) $ Benign proliferation of melanocytes.
2
Worrying signs isize, change in pigmentation, irregular outline, bleeding,
itching, inammation (may suggest transformation to melanoma Ep. 444).
Symptoms and signsMost common are acquired naevi that develop during
childhood as small, at pigmented areas and may progress to pale, raised, eshy naevi with age; congenital melanocytic naevi are larger, present from birth, and carry a higher risk of transformation to melanoma.
ManagementRefer to specialist if worrying signs are present.
Lymphadenopathy
2Worrying signs Non- tender, >3wk, >cm, hard, irregular surface, teth-
ering, weight loss, night sweats, fatigue, absence of infection.
Causes IsolatedLocal/ regional infection; Multiple Ep. 48. SymptomsLump usually in the neck, axilla, orgroin. SignsFirm, subcutaneous; usually mobile, well- dened, smooth surface. Management Enlarged lymph nodes can often be treated by ‘watchful
waiting’; however, biopsy or image if worrying signs are present.
Abscess $ Accumulation of pus within cavity due to infection or foreign
body.
Symptoms Typically single, painful, onset over days, may be febrile. SignsFluctuant, well dened, under the skin; tender, inamed (red, hot);
may spontaneously discharge; common on neck, axilla, groin, perineum.
ManagementIncision and drainage ±antibiotics eg ucloxacillin g/ 6hPO.
Boil (furuncle) $ Abscess forming in inamed hair follicle, typically
with S.aureus infection.
SymptomsSingle, painful, common on neck, axilla, groin, perineum. SignsRed, tender, hot, central punctum, may dischargepus. ManagementOften discharges spontaneously, otherwise treat as abscess;
multiple furuncles may coalesce into a carbuncle which requires drainage and extended antibiotic therapy.
War ts $ Benign proliferation of epidermis associated with infection
with human papillomavirus (HPV); can occur in varioussites.
Common warts These are papular lesions with a rough surface with black
dots within them, often on hands and feet. Spread is by direct contact.
Plantar warts (verrucas) These are usually at or inward growing with black
dots (‘heads’). Often painful if over pressureareas.
Plane warts These are small, esh- coloured, at- topped lesions usually on
the face or backs of the hands without blackdots.
Anogenital warts These are transmitted sexually and associated with dif-
ferent HPV subtypes from non- genital warts; subtypes 6 and 8 are strongly associated with cervical carcinoma, so ensure recent cervical smear in any ♀ with genital warts (or in ♀ partner, of any aected indi­vidual); subtype 6 is strongly associated with anal cancer.
Treating warts This is often dicult. Topical keratolytic agents (such as salicylic
acid or trichloroacetic acid) is usually st- line treatment, and cryotherapy (freezing) is undertaken by many general practitioners as well as in derma­tology clinics. Non- genital warts often resolve spontaneously over72– 3yr.
Actinic keratosis $ Scaly lesions seen on sun- exposed skin (fair
skinned). Can progress to skin cancer; usually treated topically.
443SKIN LUMPS
444 CHAPTER6 Skin andeyes
Skin cancers
Basal cell carcinoma(BCC)
$ Commonest form of skin cancer, accounting for 775% of diagnoses.
Risk factors Exposure to UV light (sunlight and sunbeds), PMH or FH of
BCC, exposure to arsenic.
Appearance Slow-growing lesion on sun- exposed skin; most are nodular
(waxy appearance, rolled pearly edges, and central ulceration— ‘rodent ulcer’ typically found on face); other variants include scaly patches— found on trunk) and
Investigation Biopsy and histology if large, followed by surgical excision;
pigmented.
usually fully excised initially if small and sent for histological analysis.
Treatment Excision (including Mohs’ surgery), topical chemotherapy,
radiotherapy, cryosurgery. See Box 6.3.
PrognosisBCC very rarely metastasize but can cause local tissue destruc-
tion (eg ear, lip) and very infrequently causedeath.
K Box 6.3 Mohs micrographic surgery
This involves surgical removal of the obvious tumour and a thin layer of tissue from the site. This layer is frozen and stained then exam­ined under a microscope. If there are tumour cells present, a further (deeper) layer of tissue is removed, and the process is repeated until the area is tumour- free. This procedure minimizes the need for large skin excisions, while ensuring the entire tumour is removed.
Squamous cell carcinoma(SCC)
$ This accounts for 720% of cutaneous malignancies.
Risk factors Exposure to UV light (sunlight and sunbeds) or to industrial
carcinogens (eg arsenic, tar), chronic ulcer inammation, immunosup­pression, premalignant conditions (eg Bowen’s disease, actinic keratosis).
Appearance Variable; typically eshy plaque or papule arising on sun-
exposed skin (770% on head and neck), often with bleeding, scaling, or ulceration; other forms include edge of legulcer;
Keratoacanthoma A rapidly growing nodule with cen-
Marjolin ulcerNew area of induration at
tral ulceration that usually spontaneously regresses and is considered by most as a variant ofSCC.
InvestigationUsually none, may be biopsied. TreatmentSurgical excision; topical chemotherapy, photo dynamic therapy
and immunomodulators used if unsuitable for surgery.
Prognosis If localized disease, excision gives 95% cure rate but SCC can
metastasize rapidly via local lymph nodes with poor outcome.
supercial (at, red,
4
4
Named after Dr Frederic E. Mohs who developed the original technique at the University of
Wisconsin and enthusiastically taught it to many others.
Malignant melanoma
$ Accounts for 74% of all skin cancers, but majority of skin cancer deaths.
Risk factors Pale skin, sun exposure, sunburn, tanning beds, multiple/
congenitalnaevi.
Symptoms/ signs A new, or changing mole, as assessed by ABCDE criteria:
Asymmetry, Border irregularity, Colour variation, Diameter increasing or
>6mm, Evolving over time. The Weighted 7-point checklist can also be used:
Major features (2 points each) Change in size, irregular shape or
border, irregular colour;
Minor features ( point each) Largest diameter
≥7mm, inammation, oozing or crusting, change in sensation/itch. A score of ≥3 indicates a more suspicious lesion but any concerning lesion should be referred to dermatology. A lesion which stands out from those around it is concerning—the ‘Ugly Duckling sign’.
ManagementSurgical excision, ±lymph node removal, ±chemotherapy, ±
immunotherapy (Box6.4).
Prognosis This depends upon completeness of excision, lymph node involve-
ment, presence of ulceration, and tumour thickness; these are combined to give a stage (stage I:5yr survival almost 00%; stage IV:30%).
K Box 6.4 Immunotherapy in malignant melanoma
The development of immunotherapies (such as ipilimumab, nivolumab, and pembrolizumab) and their application in malignant melanoma rep­resent a paradigm shift in the treatment of this condition with even metastatic disease now being amenable to treatment.
445SKIN CANCERS
5
5
Abbasi NR, etal. JAMA 2004;292:277 available free at Mjama.ama- assn.org
446 CHAPTER6 Skin andeyes
Legulcers
$ Loss of epithelial integrity with failure toheal.
Think about Venous insuciency, peripheral vascular disease,
neuropathic (eg DM), pressure ulcers, trauma, infection, pyoderma gangrenosum (E p. 440), vasculitides, skin cancer, steroids.
Ask aboutOnset, duration, pain, trauma, claudication; PMH Peripheral
vascular disease, iBP, CVA, MI, angina, varicose veins, DVT, DM;
DHSteroids; SHSmoking, alcohol.
Look forNumber, site, size, base, edge, depth, shape, colour, oedema,
eczema, vascular disease (peripheral pulses, hair loss, cold), neuropathy (sensation), infection (discharge, lymphadenopathy).
Investigations blds FBC, CRP, HbA
RhF, ANA,ANCA; plex
USSor CT angiogram If ABPI abnormal; Wound swab(±X- ray/ MRI
if osteomyelitis suspected);
Ankle– brachial pressure index(ABPI E p. 506) ±du-
BiopsyAtypical areas. See Table6.4.
Table6.4 Clinical assessment oflegulcers
Venous (~80%) Arterial (~0%) Neuropathic (~0%)
History Obesity, immobility,
Leg Pigmented, varicose
Site Medial aspect of
Size Can be very large Usually small Usually small
Base Usually supercial
Edge Irregular, areas of
Sensation Painful Painful Relatively painless
varicose veins, DVT
veins, swollen, hot
legs
with sloughy exudate
repeated healing and exacerbation
Intermittent claudication, HTN, DM, IHD, smoker
Shiny, hairless, cold Joint destruction
Lateral malleolus, toes, dorsum of foot
Deep with a dark, dry base, few signs of healing
Well dened, often circular
; consider ESR, complement,
c
Numbness, DM, family history
Heel, metatarsal head, pressure points
Can be very deep (extend to bone)
Surrounded by thickened skin
Management Ensure good nutrition and treat the cause, where pos-
sible. Healing often takes weeks to months and is commonly managed by community nurses, with ulcer clinic visits where appropriate:
• Venous Provided ABPI is >0.8 apply compression bandaging with
absorbable dressings to dry out the slough. Emollients and steroid creams also help; may need debridement/ grafting
• Arterial Avoid compression bandages (unless under expert guidance);
address vascular risk factors and refer to a vascular surgeon for consideration for bypass or angioplasty
• Neuropathic Careful footcare to avoid repeated injury, often needs surgical
debridement and antibiotics; osteomyelitis is common; assess for and treat coexistent vascular disease; specialist diabetic foot teamifDM
• Infection Ulcers usually have bacteria present; infection or cellulitis
should be suspected if there is pus, excessive pain, surrounding erythema, or pyrexia. Swab the ulcer and treat as for cellulitis, if clinical signs of infection (Epp. 434–5). Organisms may be colonizing the wound but not causing infection; be guided by the clinical picture rather than the swab results.
No improvement Consider other diagnoses (including TB and cancer)
or dermatitis from therapeutic agents. Ensure swabs sent; discuss with dermatology and consider biopsy. May need curettage or skin grafting.
K Box 6.5 Post- cannula swelling; ‘a tissued cannula’
This occurs when an IV cannula has not been inserted correctly and is sited only partially in the vein or outside the vein altogether, meaning that uid or drugs cannot be infused/ injected. Remove the cannula and re- site if required, elevate the aected limb and give simple analgesia forpain. If no improvement over next –2d consider possibility of infection of cannula site (Ep.434); assess swelling for collection— if in doubt request USS— if present, start IV ABx (eg co- amoxiclav .2g/ 8h IV) and discuss drainage with surgeons.
447LEG ULCERS
448 CHAPTER6 Skin andeyes
2Acute red eye emergency
3Call for senior help or speak to on- call ophthalmologist urgently if
patient has new- onset dvisual acuity (VA) in aected eye. See Fig.6.3.
Pain?
No
Yes
Yes
Large (dilated)
Yes
FOREIGN
No
Engorged
No
(constricted)
Foreign body
sensation?
Altered or
blurred vision?
Pupil size?
ACUTE ANGLE
CLOSURE
GLAUCOMA
Fig.6.3 Determining the likely cause of the acute redeye. (Red arrows indicate topics that are discussed in more detail in the text.)
Sudden
onset?
Yes
BODY
vessels?
Yes
EPISCLERITIS/
SCLERITIS
Small
No
Photophobia?
CONJUNCTIVITIS
No
SUBCONJUNCTIVAL
HAEMORRHAGE
ACUTE ANTERIOR
UVEITIS
No
Yes
KERATITIS
3Keratitis (E OHCS1p. 334.)
$ Corneal infection or inammation; may ulcerate.
Symptoms Pain, photophobia, reduced vision, and foreign body sensation,
commonly in contact lens wearer or patients with dry eyes, blepharitis, or autoimmune disorders.
Signs Conjunctival redness (can be sectoral rather than diuse as is often
the case in conjunctivitis). Fluorescein with a blue light may show punctate epithelial erosions, a white patch (corneal inltrate/ ulcer), epithelial defect, corneal haze (oedema), or hypopyon (pus in the anterior chamber).
ManagementRefer urgently for ophthalmologist, if ulceration present or sus-
pected. They may undertake corneal swabs/ scrapes to establish the cause. Antibiotic eyedrops or systemic immunosuppression may beused.
3
Episcleritis and scleritis (E OHCS1p. 333.)
$ Inammation of white outer coating; often underlying autoimmune
disorder.
Symptoms Pain and tenderness— often mild in episcleritis but severe in
scleritis (wakes patient from sleep), occasionally with photophobia and reduced vision.
Signs Mild localized redness (often involving just one sector, but occa-
sionally diuse); normal visual acuity; otherwise normal examination in episcleritis. In scleritis the globe may be tender to touch and there may be dvisual acuity.
ManagementUrgent ophthalmology review to consider scleritis. Likely ophthalmic management Topical steroids or non- steroidal agents for
episcleritis, potentially oral immunosuppressants for scleritis.
3
Acute anterior uveitis (iritis) (E OHCS1p. 332.)
$ Inammation of pigmented parts of eye; associated with systemic
disease (eg IBD, arthropathies, sarcoid); pain on pupil constriction.
SymptomsBlurred vision, photophobia, andpain. SignsRed eye, dvisual acuity, cornea usually clear, pupil may be irregular
and small, ±hypopyon (pus in the anterior chamber).
ManagementRefer urgently to ophthalmologist. Likely ophthalmic managementIntensive topical steroids, dilating agents.
3Acute angle closure glaucoma (E OHCS1p. 331.)
K iintraocular pressure due to blockage of anterior chamber drainage.
Symptoms Aching eye pain (usually unilateral and severe), often associ-
ated with N+V; blurred vision and haloes around lights are common.
Signs Red eye, dvisual acuity, hazy cornea (if severe); pupil often mid-
dilated, can be unreactive to light and oval shaped (rugby ball- like); globe tender and rm to touch. iintraocular pressure; usually >40mmHg.
Management Emergency referral to ophthalmologist; antiemetics and IV
opioids may be needed for symptoms but should not delay referral.
Likely ophthalmic management Constrict the pupil (miosis) with pilocar-
pine drops, and reduce aqueous formation with acetazolamide PO/ IV. Mannitol IV is also sometimes used to reduce intraocular pressure. Denitive care achieved with peripheral iridectomy to allow constant drainage of aqueous even when pupil dilated.
449ACUTE RED EYE EMERGENCY
450 CHAPTER6 Skin andeyes
Supercial foreign body (FB) and corneal abrasions
Symptoms Sudden- onset discomfort/ FB sensation; lacrimation and red-
ness; occurs, eg while hammering or chiselling without eye protection or following minor trauma to the eye. Acontact lens may sometimes have been ‘lost’ and cause FB sensation.
Signs Red, watering eye; FB may be visible. Always evert both top and
bottom lids to check for FBs here as well; visual acuity is usually reduced. Fluorescein with a blue light may show corneal ulceration/ abrasion(s).
Treatment Often the eye needs anaesthetizing with topical local anaesthetic
(proxymetacaine, tetracaine, or oxybuprocaine) to allow examination and treat­ment. Gently pick up FB with cotton bud, or irrigate lavishly with sterile
0.9% saline. Re- examine eye afterwards to ensure all FBs have gone. Protect the eye with an eye shield until local anaesthetic has worn o and give chloramphenicol eye drops 0.5% 4h topical or ointment % 6h topical for 3d.
speak to senior, or on- call ophthalmologist
If unable to remove FB or evidence of corneal abrasion,
.
Conjunctivitis
Symptoms Eye discharge, ±FB sensation, itch, concurrent cold, hayfever. Signs Red eye, discharge, normal visual acuity, clear cornea. See
Table6.5 for causes.
Treatment Conjunctivitis can be highly contagious so care should be taken
with hand- washing;
Bacterial Topical antibiotics (eg chloramphenicol
drops 0.5%) to both eyes every 2h while awake for 2d, then 6h forwk;
Viral May need topical antibiotics to prevent secondary infections, but
usually self- limiting;
Allergic Identify allergen if possible and encourage
avoidance; topical antihistamine, (eg azelastine), or mast cell inhibitors (cromoglicate) may oer relief; articial tears (eg Viscotears if dry eyes are a problem.
Table6.5 Determining thecause ofa conjunctivitis
Bacterial Viral Allergic
Discharge Sticky, pus- like Watery Watery
Itch +/ – +/ – ++++
Recurrent +/ – +/ – Often seasonal
Contagious Yes Yes No
Uni- or bilateral One, then both One, then both Both
Other symptoms Often none Common cold Hay fever
®
) may help
Subconjunctival haemorrhage
Symptoms Often an incidental nding by the patient and usually benign;
can sometimes initially cause mild FB sensation. There should be no pain, photophobia, or altered vision.
SignsDiuse area of bright red blood under conjunctiva, very dierent to
inamed blood vessels seen in other causes of red eye; normalVA.
TreatmentCheck BP, and if recurrent check FBC and clotting; may need
eye protection (eg tape at night) if swollen and unable to close readily; discuss with ophthalmologist only if recurrent or severe.
Sudden visualloss
2Worrying features Severe decit, additional neurology, scalppain.
Think aboutRetinal vein occlusion, retinal artery occlusion, giant cell
arteritis, retinal detachment, arteriosclerotic ischaemic optic neuropathy, vitreous haemorrhage, angle closure glaucoma.
Ask aboutLoss of vision; often painless. Look for dvisual acuity or no vision in aected eye, RAPD (suggests optic
nerve dysfunction); abnormal fundoscopy. Check for other neurological signs, for scalp pain/ tenderness, and ECG forAF.
ManagementImmediate referral to on- call ophthalmologist.
3
Giant cell (temporal) arteritis (E p. 373); dvisual acuity in
aected eye, typically with temporal headache/ pain, high ESR. May be optic neuropathy, retinal artery occlusion, or extra- ocular musclepalsy.
3
Retinal artery occlusion (E OHCS1p. 345.)
SymptomsSudden, painless, and severe loss of vision. SignsRAPD; pale retina with ‘cherry spot’ macula. Risk factorsFor vascular disease (DM, smoker, ilipids,IHD). Treatment If seen within h of onset, you may attempt to dislodge the
embolus by pressing hard on the globe, then suddenly releasing; most damage will be irreversible.
3
Retinal vein occlusion (E OHCS1p. 346.)
SymptomsSudden, painless, and severe loss of vision; may be segmental. SignsRAPD; engorged, red retina in aectedarea. Risk factors These include age, chronic glaucoma, HTN, polycythaemia. Treatment Supportive; laser photocoagulation and intravitreal steroids/
anti- VEGF can prevent neovascularization and treat macular oedema.
3
Vitreous haemorrhage (E OHCS1p. 347.)
SymptomsSudden painless loss of vision; oaters. SignsRAPD; loss of red reex; unable to see retina. Risk factorsDM (proliferative retinopathy), coagulopathy, trauma. Treatment Haemorrhage should resolve spontaneously; prevent further
episodes by laser photocoagulation of peripheral retina; vitrectomy if persistent.
3
Retinal detachment
SymptomsFloaters, ashing lights, shadow across vision, loss of vision. SignsRAPD; loss of red reex, detachment on fundoscopy. Risk factorsMyopia, iage, intraocular surgery, Marfan’s. TreatmentUrgent ophthalmology review for vitrectomy or closure.
Optic neuritis This is often associated with a subacute, unilateral loss
of vision, with aching, pain on eye movements, and loss of colour vision. Relative aerent pupillary defect; optic nerve usually appears normal when inammation is retrobulbar; disease (may be a rst presentation of MS); resolution occurring over a fewweeks.
Causes These include demyelinating
Treatment Supportive, with
451SUDDEN VISUAL LOSS
452 CHAPTER6 Skin andeyes
Gradual visualloss
Think about Refractive error, cataracts, macular degeneration,
chronic glaucoma, diabetic retinopathy, optic atrophy, drug toxicity, optic neuroma; inherited disease.
Ask about Painless loss of vision, symptoms of underlying disease. Look for dvisual acuity or no vision in aected eye, pupil unresponsive
to light or RAPD (suggest optic nerve disorder), abnormal cornea, lens, retina, or optic disc on fundoscopy.
Management This needs full ophthalmic assessment. If in- patient, try
and arrange for review before discharge, or refer as an out- patient. See also Box6.6.
Cataracts(E OHCS1p. 350.)
Causes Age- related, DM, steroids, trauma, eye surgery; congenital. SymptomsBlurred vision (bilateral), poor distance judgement (unilateral). Signs dvisual acuity, cataract visible in lens; retina and red reex visible
unless cataract isdense.
TreatmentCataract surgery is performed on a single eye at a time if the
cataract(s) are interfering with lifestyle (eg reading or driving). They are usually done as a day- case procedure under local anaesthetic; the lens is removed (phaecoemulsion) and an articial lens implanted.
Age- related macular degeneration(E OHCS1p. 352.)
CausesAgeing, smoking. SymptomsDeterioration of central vision. Signs dvisual acuity, but normal visual elds; normal disc, but macula
often pigmented or bleeding upon fundoscopy.
Treatment This is aimed at reducing further visual loss; ‘wet’ (neovascular)
forms can be treated with intravitreal anti- VEGF injections.
Chronic (open-angle) glaucoma This results in peripheral visual eld
loss in those with iintraocular pressure(IOP); the opticdisc; β- blockers, eg timolol, or carbonic anhydrase inhibitors, eg dorzolamide) or ireabsorption (prostaglandin drops, eg latanoprost); surgery involves trabeculectomy (allows aqueous drainage into subconjunctiva).
Treatment This aims to dIOP by daqueous formation (topical
K Box 6.6 Registration ofvisual impairment
A consultant ophthalmologist can apply on behalf of a patient to register as blind or partially sighted; this is a voluntary not a statutory process. Registration entitles the individual to some tax allowances, benets, and some concessions for public transport and other public facilities. Generally acuity <3/ 60 (after correction) qualies as ‘blind’, while corrected vision <6/ 60 qualies as ‘par­tially sighted’; restriction of visual elds or loss of central vision may also qualify. The Royal National Institute of Blind People advises on benet entitlements, aids for the house, and independent living, and for guidedogs: Royal National Institute of BlindPeople 05 Judd Street, London, WCH9NE 0303 23 9999 Mwww.rnib.org.uk
SignsCupping and atrophy of